Stem cell showdown: which transplant offers better odds for T-Cell cancer patients?
NCT ID NCT07577531
First seen May 12, 2026 · Last updated May 17, 2026 · Updated 1 time
Summary
This study looks at 84 people with T-cell acute lymphoblastic leukemia or lymphoma who are in their first complete remission after chemotherapy. Researchers want to see if using the patient's own stem cells or a donor's stem cells for a transplant works better to keep the cancer from coming back. The goal is to find the safest and most effective consolidation treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.